free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Orchid Pharma gets EIR from US FDA for its Alathur facility

expressbpdSeptember 25, 2017

Tag: Orchid Pharma , EIR , US FDA

The facility was inspected by the US FDA

Orchid Pharma has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tamil Nadu.

The company has received EIR from the United States Food and Drug Administration (US FDA) based on the successful inspection of the active pharmaceutical ingredients (API) manufacturing facility at Alathur. The facility was inspected by the US FDA, Orchid Pharma said in a filing to BSE.

Previous:Zydus Pharma recalls 44,800 bottles of antidepressant in US

Next:Agilent Technologies launches triple quadrupole mass spectrometer in India

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service